Mode
Text Size
Log in / Sign up
N/A N=20 Randomized Single-blind Prevention

Comparative Effectiveness of Unilateral vs. Bilateral Pulmonary Collapse in Cardiac De-airing

Brain Ischemia · Reduction of Cerebral Air Emboli

Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Jan 2018
Primary outcome: Primary: Quantitative Assessment of Air Embolism to the Brain After Completion of Open Left Heart Surgery — 46; 32 gaseous cerebral microemboli — p=1.00

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Bilateral Open Pleurae (Procedure); Right Pleura Open (Procedure)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Lund University
Primary completion
Jun 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
Quantitative Assessment of Air Embolism to the Brain After Completion of Open Left Heart Surgery
30; 34 1
PRIMARY
Quantitative Assessment of Air Embolism to the Brain After Completion of Open Left Heart Surgery
30; 34 1
PRIMARY
Quantitative Assessment of Air Embolism to the Brain After Completion of Open Left Heart Surgery
30; 34 1
PRIMARY
Number of Participants With <=Grade I Air Emboli as Assessed by Trans-esophageal Echocardiography (TEE) After Finished De-airing.
9; 10
PRIMARY
Number of Participants With <=Grade I Air Emboli as Assessed by Trans-esophageal Echocardiography (TEE) After Finished De-airing.
9; 10
PRIMARY
Number of Participants With <=Grade I Air Emboli as Assessed by Trans-esophageal Echocardiography (TEE) After Finished De-airing.
9; 10
SECONDARY
Duration of the De-airing Procedure
8; 10

Summary

To compare the effectiveness of unilateral pulmonary collapse (right lung) to bilateral pulmonary collapse for cardiac de-airing in open left-sided heart surgery.

Eligibility Criteria

Inclusion Criteria

  • Aortic valve pathology requiring surgery.

Exclusion Criteria

  • Prior thoracic surgery,
  • Severe chronic obstructive pulmonary disease and/or
  • Emphysema.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02119871). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search